Detalhe da pesquisa
1.
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
Lancet;
397(10275): 682-694, 2021 02 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33524311
2.
Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine.
J Infect Dis;
224(10): 1699-1706, 2021 11 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34480575